ICAD INC

ICAD03 Dec 2024
Healthcare
$1.77
+0.01 (+1.45%)
Lowest Today
$1.74
Highest Today
$1.79
Today’s Open
$1.77
Prev. Close
$1.73
52 Week High
$2.65
52 Week Low
$1.18
To Invest in ICAD INC

ICAD INC

Healthcare
ICAD03 Dec 2024
+0.01 (+1.45%)
1M
3M
6M
1Y
5Y
Low
$1.74
Day’s Range
High
$1.79
1.74
52 Week Low
$1.18
52-Week Range
52 Week High
$2.65
1.18
1 Day
-
1 Week
+9.49%
1 month return
-6.98%
3 month return
+13.07%
6 month return
+15.33%
1 Year return
+5.48%
3 Years return
-76.58%
5 Years return
-77.38%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
4.3
Vanguard Total Stock Mkt Idx Inv
2.93
Arnhold & S. Bleichroeder Advisers, LLC
2.56
Portolan Capital Management, LLC
2.48
First Eagle Small Cap Opportunity I
2.38
First Eagle US Small Cap Strategy
2.38
Renaissance Technologies Corp
2.28

Market Status

Fundamentals
Market Cap
46.65 mln
PB Ratio
1.59
PE Ratio
0
Enterprise Value
28.27 mln
Total Assets
41.42 mln
Volume

Company Financials

Fund house & investment objective

Company Information
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
Organisation
ICAD INC
Employees
67
Industry
Medical Devices
CEO
Ms. Dana R. Brown
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities